Products
MR PHARMA is a leader in the development of products for third parties and also has its own elaboration of the following products:
Product | Presentation | Pharmaceutical Form | Active Principle | Therapeutic Action |
DALMONAR® | Vial | Liposomal Dispersion Injection | Liposomal Doxorubicin Hydrochloride | Antineoplastic Agent |
REMICIT ® | Vial | Lyophilized Injectable | Remifentanil hydrochloride | Last Generation Anaesthetic |
UNIMEX® | Ampoule | Injectable solution | Noretisterone enanthate + Estradiol valerate | Monthly contraceptive |
The company conducts an active search of clients in the international pharmaceutical market to arrange agreements for the commercialization of its own molecules.
Products available for registration abroad:
ACTIVE PHARMACEUTICAL INGREDIENTS | DOSAGE FORM |
Zoledronic Acid | Lyophilized |
Atracurium 10 mg | Injectable solution |
Azithromycin 500 mg | Lyophilized |
Betamethasone acetate + betamethasone phosphate | Injectable suspension |
Betamethasone dipropionate + Betamethasone disodium phosphate |
Injectable suspension |
Betamethasone Sodium Phosphate | Injectable solution |
Clarithromycin 500 mg | Lyophilized |
Dexamethasone | Injectable suspension |
Dexamethasone Phosphate + Acetate | Injectable suspension |
Doxorubicin (Pegylated Liposomal) 50mg | Liposomal Dispersion |
Erythropoietin 1000, 2000, 4000 and 10000 IU | Lyophilized and Injectable solution |
Leucovorine 50 mg | Lyophilized |
Mesna 200 mg and 400 mg | Injectable solution |
Norestisterone 50 mg + Estradiol Valerate 5 mg |
Injectable suspension
|
Omeprazole 40mg | Lyophilized |
Ondansetron 4 mg and 8 mg | Injectable solution |
Pancuronium 4 mg / 2ml | Injectable solution |
Remifentanil 1 mg, 2 mg and 5 mg | Lyophilized |
Vecuronium 4 mg/ml | Lyophilized |
Estados Unidos 5105
(B1667JHM) Tortuguitas, Buenos Aires, Argentina
Tel: +54 (3327) 445858
E-mail: web@mrpharma.com.ar
Sections of interest